4 completed. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 4 |
Follow Central Retinal Vein Occlusion: new trials by email Literature Review of Central Retinal Vein Occlusion trials Research Report on Central Retinal Vein Occlusion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of a Treat and Extend Regimen of Intravitreal Aflibercept for Macular Edema Secondary to CRVO Aflibercept (Eylea, BAY86-5321) - Central Retinal Vein Occlusion | Phase 4 | Completed | Bayer | 162 | 2016-06-10 | 2020-07-08 |
| Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVO Aflibercept - Retinal Vein Occlusion, Diabetic Macular Edema | Phase 4 | Completed | Justis Ehlers | 31 | 2015-08-18 | 2021-05-12 |
| Comparing Injection Frequency Between Aflibercept and Ranibizumab in Patients With CRVO With a Treat& Extend Regimen Aflibercept, Ranibizumab - Central Retinal Vein Occlusion | Phase 4 | Completed | Anders Kvanta | 40 | 2014-10-01 | 2020-12-04 |
| Hemodilution Versus Ranibizumab in Early-onset Central Retinal Vein Occlusion ranibizumab, hemodilution - Central Retinal Vein Occlusion | Phase 4 | Completed | Centre Hospitalier Intercommunal Creteil | 45 | 2010-01-01 | 2014-08-13 |
Retinal Vein Occlusion (4) · Macular Edema (1)
Cardiovascular Diseases (4) · Embolism and Thrombosis (4) · Eye Diseases (4) · Retinal Diseases (4) · Thrombosis (4) · Vascular Diseases (4) · Venous Thrombosis (4) · Macular Degeneration (1) · Retinal Degeneration (1)
aflibercept (3) · Ranibizumab (2) · Hemodilution (1)
Anders Kvanta (1) · Bayer (1) · Centre Hospitalier Intercommunal Creteil (1) · Justis Ehlers (1)
France (2) · Australia (1) · Canada (1) · Denmark (1) · Germany (1) · Italy (1) · Spain (1) · Sweden (1) · United Kingdom (1) · United States (1)
Justis P Ehlers, MD (1) · Sofie Westman (1)
PMID 27409478, PMID 31757691, PMID 33556381
2009 (1), 2014 (1)